These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26924356)

  • 1. Evaluation of drug-carrier interactions in quaternary powder mixtures containing perindopril tert-butylamine and indapamide.
    Voelkel A; Milczewska K; Teżyk M; Milanowski B; Lulek J
    Int J Pharm; 2016 Apr; 503(1-2):29-35. PubMed ID: 26924356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the surface energy of lubricated pharmaceutical powders by inverse gas chromatography.
    Swaminathan V; Cobb J; Saracovan I
    Int J Pharm; 2006 Apr; 312(1-2):158-65. PubMed ID: 16469458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of independent component analysis on Raman images of a pharmaceutical drug product: pure spectra determination and spatial distribution of constituents.
    Boiret M; Rutledge DN; Gorretta N; Ginot YM; Roger JM
    J Pharm Biomed Anal; 2014 Mar; 90():78-84. PubMed ID: 24333706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.
    Adi H; Traini D; Chan HK; Young PM
    J Pharm Sci; 2008 Jul; 97(7):2780-8. PubMed ID: 17894369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution profiles of perindopril and indapamide in their fixed-dose formulations by a new HPLC method and different mathematical approaches.
    Gumieniczek A; Mączka P; Komsta Ł; Pietraś R
    Acta Pharm; 2015 Sep; 65(3):235-52. PubMed ID: 26431103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW; Lim LT; Heng PW
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of surface modification on surface energy of lactose and performance of dry powder inhalations].
    Jiang RG; Zhang PW; Wang LQ; Liu H; Pan WS; Wang CL
    Yao Xue Xue Bao; 2005 Apr; 40(4):373-6. PubMed ID: 16011271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of colloidal silica action to improve flow properties of pharmaceutical excipients.
    Tran DT; Majerová D; Veselý M; Kulaviak L; Ruzicka MC; Zámostný P
    Int J Pharm; 2019 Feb; 556():383-394. PubMed ID: 30529657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modification of lactose inhalation blends by moisture.
    Watling CP; Elliott JA; Scruton C; Cameron RE
    Int J Pharm; 2010 May; 391(1-2):29-37. PubMed ID: 20156536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inverse gas chromatography measurement conditions on surface energy parameters of lactose monohydrate.
    Planinsek O; Zadnik J; Rozman S; Kunaver M; Dreu R; Srcic S
    Int J Pharm; 2003 Apr; 256(1-2):17-23. PubMed ID: 12695007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
    Vehovec T; Gartner A; Planinšek O; Obreza A
    Acta Pharm; 2012 Dec; 62(4):515-28. PubMed ID: 23333887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas-pressurized dispersive powder flow tester for low volume sample characterization.
    Majid AM; Wong TW
    Int J Pharm; 2013 May; 448(1):150-8. PubMed ID: 23506957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy.
    Traini D; Scalia S; Adi H; Marangoni E; Young PM
    Int J Pharm; 2012 Nov; 438(1-2):150-9. PubMed ID: 22964399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.